| View |
|
DRP-263-05
|
Paracetamol + Ibuprofen
|
Prozet
|
325mg/200mg
|
Tablet
|
Analgesic/Antipyretic
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
12 April 2023
|
30 June 2028
|
| View |
|
DRP-11107-03
|
Ascorbic Acid + Zinc
|
InnoC + Z
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) / 10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
CapsuleAlu/Deep Red PVC Blister Pack x 10's (Box of 10's, 30'sand 100's)
|
Vitamin / Mineral
|
Pharmatechnica Laboratory, Inc
|
Philippines
|
CLIDP Conversion
|
29 March 2022
|
02 February 2027
|
| View |
|
DRP-11620-02
|
Febuxostat
|
Febuwise
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Gracure Pharmaceutical Ltd.
|
India
|
CLIDP Conversion
|
12 July 2022
|
04 April 2027
|
| View |
|
DRP-4693-13
|
Losartan Potassium
|
Unbranded
|
100 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor Blocker
|
Mediwin Pharmaceuticals
|
India
|
Renewal
|
13 December 2022
|
06 September 2028
|
| View |
|
DRP-6527-07
|
Meropenem (as Trihydrate)
|
Ropimed
|
1 g
|
Powder for Solution for Injection (IV)
|
Antibacterial (Carbapenem)
|
Zeiss Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 April 2022
|
12 February 2026
|
| View |
|
DRP-9391-01
|
Telmisartan
|
Telwin 80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics & Chemicals Limited
|
India
|
CLIDP Conversion
|
23 September 2021
|
02 March 2026
|
| View |
|
DRP-9390-03
|
Telmisartan
|
Tel-S
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics & Chemicals Ltd.
|
India
|
CLIDP Conversion
|
22 September 2021
|
02 March 2026
|
| View |
|
DRP-10929-08
|
Norepinephrine (As Bitartrate)
|
Freeron
|
1mg/mL (4mg/4mL)
|
Solution For Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
20 June 2022
|
31 January 2027
|
| View |
|
DRP-8586-14
|
Trimetazidine dihydrochloride
|
Xinprotec
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
25 April 2024
|
18 December 2029
|
| View |
|
DRP-10511-02
|
Febuxostat
|
Fexogout-80
|
80 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 January 2022
|
07 October 2026
|
| View |
|
DRP-10929-04
|
Norepinephrine (As Bitartrate)
|
Neurophrine
|
1mg/mL (4mg/4mL)
|
Solution for Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
12 May 2022
|
31 January 2027
|
| View |
|
DRP-11108-02
|
Butamirate Citrate
|
Butaciram
|
50 mg
|
Film-Coated Sustained-Release Tablet
|
Antitussive
|
Orion Pharma Ltd
|
Bangladesh
|
CLIDP Conversion
|
27 May 2022
|
03 February 2027
|
| View |
|
DRP-7097-04
|
Ursodeoxycholic Acid
|
Trisodex
|
300 mg
|
Film-Coated Tablet
|
Bile Salt
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
30 August 2022
|
14 March 2027
|
| View |
|
DRP-11154-06
|
Nicardipine Hydrochloride
|
None
|
1mg/mL (10mg/10mL)
|
Solution for Injection (IV Infusion)
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
01 August 2022
|
11 February 2027
|
| View |
|
DRP-8584-13
|
Pantoprazole (as sodium sesquihydrate) + Domperidone
|
Pantorone
|
40 mg/30 mg
|
Modified-Release Capsule
|
Proton Pump Inhibitor/Gastrokinetic
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
28 February 2022
|
18 December 2024
|
| View |
|
DRP-10929-01
|
Norepinephrine (As Bitartrate)
|
Norephimed
|
1mg/mL (4mg/4mL)
|
Solution For Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
18 May 2022
|
31 January 2027
|
| View |
|
DRP-10512-02
|
Febuxostat
|
None
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd
|
India
|
c
|
07 January 2022
|
07 October 2026
|
| View |
|
DRP-11700-02
|
Omeprazole (as sodium)
|
OMEHIL
|
40 mg
|
Lyophilized Powder for Intravenous Injection / Infusion
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
23 July 2022
|
25 April 2027
|
| View |
|
DRP-8637-09
|
Butamirate citrate
|
Butacap
|
50 mg
|
Sustained-Release Tablet
|
Antitussives
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
29 April 2022
|
20 January 2025
|
| View |
|
DRP-12407-02
|
Cefalexin (as monohydrate)
|
Regilexin
|
125 mg/5 mL
|
Powder for Suspension
|
Antibacterial (First Generation Cephalosporin)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
03 October 2022
|
21 July 2027
|